Programme Overview
Click to view session details.
| 08:00-11:00 |
|
Hall A |
| 08:00-11:00 |
|
Hall D |
| 08:00-11:00 |
|
Hall H |
| 08:00-11:00 |
|
Room 133 |
| 14:00-18:00 |
Optimising outcomes for hepatitis patients using enhanced care models’ |
Room 133 |
| 18:00-19:30 |
Sponsors:
Gilead
,
F. Hoffmann-La Roche
|
Halls A & F |
| 07:30-08:30 |
Sponsors:
Abbott
,
Grifols
,
Merz
,
Sirtex
|
Halls D,E,F & H |
| 18:30-20:00 |
Sponsors:
Janssen Pharmaceuticals
,
Bayer Pharma AG
|
Halls B & H |
| 07:30-08:30 |
|
Room 134 |
| 11:30-12:30 |
Experimental Models in Hepatology: clarifying aetio-pathogenesis in searching for therapeutic targets |
Hall E |
| 14:00-15:45 |
|
Hall G |
| 16:00-18:00 |
|
Hall E |
| 18:30-20:00 |
Sponsors:
Boehringer Ingelheim
,
MSD
|
Halls A & C |
| 11:15-13:15 |
|
Hall E |
| 18:00-19:00 |
Sponsors:
BMS-HCV
|
Hall C |
| 08:30-10:00 |
Sponsors:
Novartis
,
BMS
|
Halls B & G |